a developer of biopharmaceuticals
Industry Biotechnology
A.I.dvisor tells us that CUE and PRME have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CUE and PRME's prices will move in lockstep.
Ticker / NAME | Correlation To CUE | 1D Price Change % | ||
---|---|---|---|---|
CUE | 100% | N/A | ||
PRME - CUE | 31% Poorly correlated | -9.22% | ||
AVTE - CUE | 29% Poorly correlated | -2.66% | ||
RIGL - CUE | 29% Poorly correlated | +0.18% | ||
ACLX - CUE | 28% Poorly correlated | -5.05% | ||
PCVX - CUE | 28% Poorly correlated | -4.09% | ||
More |
Ticker / NAME | Correlation To CUE | 1D Price Change % |
---|---|---|
CUE | 100% | N/A |
biopharmaceuticals theme (50 stocks) | 26% Poorly correlated | -2.60% |
drugs theme (254 stocks) | 23% Poorly correlated | -1.67% |
biotechnology theme (238 stocks) | 12% Poorly correlated | -1.76% |